23 /100
LOW RISK
Score updated May 29, 2026

MTNB — Matinas BioPharma Holdings, Inc. Dilution Risk Tracker

Track MTNB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MTNB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.59 below $1 exchange minimum
🔔 Track MTNB — Get forecast alerts →

💹 Market Data

Market Cap$5.09M
Shares Outstanding6.41M
Float5.23M
Cash$4.00M
Debt$1.35M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 59.8% shares (2025Q4 vs prior)
30 institutional holders · 475.9K shares
#1 CITADEL ADVISORS LLC 65.7K shares
#2 Holos Integrated Wealth LLC 65.0K shares
#3 VANGUARD GROUP INC 59.7K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.4K
Days to Cover1.0
% of Float0.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2017
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MTNB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MTNB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MTNB
📊 MTNB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MTNB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.